Company profile
Ocumetics Technology Corp.
OTC: OTCFF · Healthcare · Medical - Instruments & Supplies
Canadian filerHQ Calgary, ABReports USD
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH 14DQ —GM —SS 25
v0.1 · 35/100 weight · pillars only
↑ disclosure history, market scale · ↓ Piotroski F, workforce scale
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$3.8M
Employees
3
as of 2026-08-21
Market cap
$18.3M
as of 2026-08-21
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$00 CAD2025
Net income-$3.8M-5.4M CAD2025
Operating income-$3.8M-5.4M CAD2025
Total assets$1.4M1.9M CAD2025
Liabilities$4.3M5.8M CAD2025
Equity-$2.9M-3.9M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Ocumetics Technology Corp.’s revenue?
Ocumetics Technology Corp. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
EOM Pharmaceuticals Holdings, Inc.——Barinthus Biotherapeutics plc39DRein Therapeutics Inc.36DKALA BIO, Inc.30DTvardi Therapeutics, Inc.35DPalatin Technologies, Inc.40DKey facts
CEODean E. Burns
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersCalgary, AB
ExchangeOTC: OTCFF
Employees3
IPO date2021-11-01
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.